Image

Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS

Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS

Not Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this study was to examine the effects of bladder training and pelvic floor exercise training programs given in addition to Botulinum Toxin-A (BTx-A) application on urinary symptoms and quality of life in patients with Overactive Bladder Syndrome (AAMS) who do not respond to conservative treatments.

Individuals who meet the criteria for inclusion in the study and agree to participate in the study will be divided into 2 separate research branches.The patients to be included in the study will be divided into two groups as "Group 1=Botox + physiotherapy " or "Group 2=Botox group ". In addition to the BTx-A application, bladder training and pelvic floor exercise training will be applied to patients in the first group, while standard patient training will be provided to patients in the second group.

Severity of urinary symptoms, quality of life and subjective perception of improvement Before BTx-A application, 2 weeks and 12 weeks after BTX-A application, International Incontinence Consultation Questionnaire - Women's Lower Urinary Tract Symptoms (ICIQ-FLUTS), 1-hour ped test, International Incontinence Consultation- Lower Urinary Tract Symptoms Quality of Life Scale (ICIQ-LUTS) and Global Perception of Improvement will be evaluated.

Eligibility

Inclusion Criteria:

  • over the age of 18 (those with a Mini Mental Test score of 24 and above for individuals over the age of 65),
  • Who has Non-Neurogenic Overactive Bladder Syndrome,
  • Patients who received Routine Botulinum Toxin-A administration because they did not respond to conservative treatment,
  • Patients who volunteer to participate in the study will be included.

Exclusion Criteria:

  • Patients with Neurogenic Overactive Bladder Syndrome,
  • Pregnant Women,
  • Lack of cooperation in evaluation and/or treatment and lack of literacy status,
  • Patients with urogynocological/anatomical abnormalities,
  • Patients receiving pelvic radiation therapy,
  • Patients with psychiatric or neurogenic disorders and
  • Patients who have not given consent to the study and do not have an informed consent form (BGOF).

Study details
    Overactive Bladder Syndrome (OABS)

NCT06209333

Hacettepe University

26 February 2026

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.